ASTRAZENECA PLC (AZN)
Clinical trial NCT05704829 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2029-06-01 → 2030-09-01 3. primary completion date: 2025-06-18 → 2030-06-01 4. enrollment: 402 → 702 participants
Clinical trial NCT05704829 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2029-06-01 → 2030-09-01 3. primary completion date: 2025-06-18 → 2030-06-01 4. enrollment: 402 → 702 participants
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical